Works matching IS 00282685 AND DT 2023 AND VI 70 AND IP 6

Results: 10

Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 811, doi. 10.4149/neo_2023_230806N413
By:
- Dongming LIU;
- Han MU;
- Changfu LIU;
- Weihao ZHANG;
- Yunlong CUI;
- Qiang WU;
- Xiaolin ZHU;
- Feng FANG;
- Wei ZHANG;
- Wenge XING;
- Qiang LI;
- Tianqiang SONG;
- Wei LU;
- Huikai LI
Publication type:
Article
Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 804, doi. 10.4149/neo_2023_230910N480
By:
- Tian WANG;
- Jie WANG;
- Tianci TANG;
- Li WANG;
- Yi LI;
- Xinmao SONG
Publication type:
Article
Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 796, doi. 10.4149/neo_2023_230721N380
By:
- ROSOVA, Blanka;
- PROKS, Jan;
- FILIPOVA, Alzbeta;
- NIKOLOV, Dimitar Hadzi;
- CHLOUPKOVA, Renata;
- RICHTER, Igor;
- SZABO, Arpad;
- ROZSYPALOVA, Aneta;
- MATEJ, Radoslav;
- MELICHAR, Bohuslav;
- BUCHLER, Tomas;
- DVORAK, Josef
Publication type:
Article
Innervation density and types of nerves in prostate cancer.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 787, doi. 10.4149/neo_2023_231116N593
By:
- BLASKO, Filip;
- KRIVOSIKOVA, Lucia;
- BABAL, Pavel;
- BREZA, Jan;
- TREBATICKY, Branislav;
- KURUC, Roman;
- MRAVEC, Boris;
- JANEGA, Pavol
Publication type:
Article
CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 777, doi. 10.4149/neo_2023_230103N4
By:
- Xinlin YANG;
- Miao ZHANG;
- Wei XIA;
- Zhongchao MAI;
- Ying YE;
- Bin ZHAO;
- Yanan SONG
Publication type:
Article
CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 761, doi. 10.4149/neo_2023_221021N1039
By:
- Zhi WANG;
- Tao ZHOU;
- Xubo CHEN;
- Xinhua ZHU;
- Bing LIAO;
- Jianguo LIU;
- Siqi LI;
- Ting TAN;
- Yuehui LIU
Publication type:
Article
Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 747, doi. 10.4149/neo_2023_230125N41
By:
- Jia YUAN;
- Yue CHANG;
- Yalan DAI;
- Yutong CHEN;
- Rongbin YUE;
- Linjuan ZENG
Publication type:
Article
FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 733, doi. 10.4149/neo_2023_230104N8
By:
- Yanghui BI;
- Yanfang YANG;
- Yong ZHANG;
- Caixia CHENG;
- Peisen TANG;
- Heng XIAO;
- Fajia YUAN;
- Weiwei WU;
- Bin YANG
Publication type:
Article
The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 722, doi. 10.4149/neo_2023_230614N310
By:
- Yongkun WANG;
- Yingchun LI;
- Cui RAN;
- Wenjun LE;
- Jiaxing DONG;
- Xujing WANG;
- Bo CHEN;
- Xiaohua JIANG
Publication type:
Article
miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy.
Published in:
Neoplasma, 2023, v. 70, n. 6, p. 713, doi. 10.4149/neo_2023_230711N362
By:
- Tian GAO;
- Yong-Qing LIN;
- Hai-Yan YE;
- Wu-Mei LIN
Publication type:
Article